Clinical and pharmacologic aspects of blinatumomab in the treatment of B-cell acute lymphoblastic leukemia
Craig A Portell, Candice M Wenzell, Anjali S Advani Leukemia Program, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA Abstract: Acute lymphoblastic leukemia (ALL) in adults remains a challenging disease to treat, and novel therapies are needed. Precursor-B ALL comprises 80% of cases,...
Guardado en:
Autores principales: | Portell CA, Wenzell CM, Advani AS |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2013
|
Materias: | |
Acceso en línea: | https://doaj.org/article/22d8a228028f4c9eb7976618ce4b5032 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Special issue of clinical pharmacology: advances and applications in new protein therapeutics modulating tumor immunity
por: Frankel AE
Publicado: (2013) -
Clinical Pharmacology: Advances and Applications
Publicado: (2010) -
Development of best practices in physiologically based pharmacokinetic modeling to support clinical pharmacology regulatory decision‐making—A workshop summary
por: Daphney Jean, et al.
Publicado: (2021) -
Pharmacological properties of selenium and its preparations: from antioxidant to neuroprotector
por: Igor F. Belenichev, et al.
Publicado: (2021) -
Optimal management of Barrett's esophagus: pharmacologic, endoscopic, and surgical interventions
por: Konda VJA, et al.
Publicado: (2011)